At Slingshot Software, we understand how high the stakes are in the pharmaceutical industry when it comes to compliance. That’s why we’re proud to spotlight the work of our sister company, Slingshot Pharma, which is making a measurable impact helping pharma and life sciences companies prepare for and pass their 21 CFR Part 11 audits with confidence.
Through structured compliance assessments, Slingshot Pharma helps organizations identify critical gaps in their current systems and align on the right technology solutions for secure, auditable, and validated electronic records and signatures.
In their latest blog post, "21 CFR Part 11 Assessment Guide: How to Pass Your Next Audit", Slingshot Pharma lays out a clear, step-by-step framework to help companies:
- Understand what regulators are really looking for
- Evaluate internal readiness
- Select the right software solution for long-term compliance
Whether you’re a contract manufacturer, biotech startup, or established pharma firm, a strategic assessment and a Part 11-ready solution can make all the difference in audit outcomes.
To learn more, visit slingshotpharma.com or check out the full guide here.